AGENDA

  •   TIME (Pacific Time)  SESSION 
    8:00am

    Welcome

    • Jill Hawkins, Founder & President, FAM177A1 Research Fund
    • Ethan Perlstien, CEO, Perlara PBC

    Watch Video

    8:15am

    Genetics 101: Unravelling FAM177A1

    • Charlie Steward, Ph.D., Head of Patient and Participation Engagement at Genomics England

    Watch Video

    8:30am

    Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder; Q&A

    • Dr. Nicole Legro, MD; Georgetown Medstar University Hospital
    • Jennefer Kohler, MS LGCS; Stanford Center for Undiagnosed Diseases

    Watch Video

    8:50am

    Family Story

    Watch Video

    8:55am

    FAM177A1 Zebrafish; Q&A

    • Lilianna Solnica-Krezel, Ph.D Head Department of Developmental Biology Co-Director, Center of Regenerative Medicine Washington University School of Medicine
    • Jimann Shin, Ph.D., Solnica-Krezel Lab WUSTL

    Watch Video

    9:15am

    The elusive role of FAM177A1 in the Golgi complex; Q&A

    • Berrak Ugur, Ph.D; Associate Research Scientist; De Camilli Lab, Yale University

    Not Available

    9:35am

    Family Story

    Watch Video

    9:45am

    The FAM177A1-Associated Disease murine (mouse) model; Q&A

    • Matt Simon, Ph.D; Study Director, Rare Disease Translational Center, The Jackson Laboratory

    Watch Video

    10:00am

    Drug Repurposing and Biomarker Studies; Q&A

    • Ethan Perlstein, Ph.D. CEO Perlara PBC

    Watch Video

    10:15am

    Family Story

    Watch Video

    10:20am

    Introduction to gene therapy and considerations for FAM177A1; Q&A

    • Matt Fuller, Ph.D., Executive Director; Gene Therapy Research at Ultragenyx

    Watch Video

    10:40am

    Natural History is Power: The Rare Patient’s Most Valuable Resource; Q&A

    • Terry Jo Bichell, Ph.D., Founder/Director at COMBINEDBrain

    Watch Video

    11:00am

    Closing remarks and discussion

    Watch Video